Skip to content
Disclosery

Paradigm Biocapital Advisors LP: RVMD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on RVMD, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 6,361,323 RVMD shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 6,361,323 shares
    Change vs previous 13F -294,380 shares

    22.31% of the 13F portfolio, value $1,191,348,571.

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 6,655,703 shares
    Change vs previous 13F +11,300 shares

    13.23% of the 13F portfolio, value $647,267,117.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 6,644,403 shares
    Change vs previous 13F +421,112 shares

    14.17% of the 13F portfolio, value $529,226,699.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 6,223,291 shares
    Change vs previous 13F +130,000 shares

    8.6% of the 13F portfolio, value $290,627,690.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 6,093,291 shares
    Change vs previous 13F -84,820 shares

    9.57% of the 13F portfolio, value $224,172,176.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 6,178,111 shares
    Change vs previous 13F -375,000 shares

    10.06% of the 13F portfolio, value $218,458,005.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 6,553,111 shares
    Change vs previous 13F +1,239,022 shares

    9.97% of the 13F portfolio, value $286,633,075.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 5,314,089 shares
    Change vs previous 13F not available

    8.43% of the 13F portfolio, value $240,993,936.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).